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Introduction 
Cancer is certainly one of the most dreaded 
disease in humans.1 Already billions of dollars has 
been invested into cancer research. These researches 
had led to several promising drugs which are currently 
being used in cancer treatments.2 However, still to 
many patients a cure for their cancerous cells had been 
elusive mainly due to drug resistance. On the other 
side, for those who were luckier in which drugs were 
effective, it was found to be accompanied with 
unpleasant side effects.3 Therefore, it is important to 
continue explore novel targets that could slow and 
arrest the growth of cancerous cells while having 
minimal side effects to the body. Phytomedicine has 
been in practice since the ancient days. Many modern 
anti-cancer drugs are analogues of natural 
compounds.4 More recently, researchers have been 
trying out combination or adjunct therapies where 
promising phytomedicines were used along with 
standard medications.5 Although, in some cases it was 
found to be minimally effective, it is still believed that 
the right combination of drug and the natural 
component could improve the overall effectiveness of 
the treatment. It is believed that phytomedicines which 
are rich in antioxidant molecules might be helping to 
protect normal cells from the harmful effects of anti-
cancer drugs.6 Accordingly, research in this direction 
seems promising and warrants more attention. 
  
Anti-cancer properties of Murraya koenigii  
In this article7, Bindu Noolu and Ayesha 
Ismail has reported the potential of Murraya koenigii 
(commonly called curry leaf plant and widely used as a 
seasoning ingredient in South-Indian cuisine) to arrest 
cell proliferation by inhibiting proteasome function in 
four different cancer cell lines (Caco2, HepG2, HeLa 
and LNCaP) representing colon, liver, cervical and 
prostate cancers. It is important to test on various cell 
lines as IC50 varies greatly with types of cancer. Few 
studies have earlier reported on the anti-cancer effects 
of Morraya Koenigii8, 9, but this is the first study that 
did a dose response on more than one cancer cell 
types. Further, dose dependent inhibition of 26S 
proteasome activity was also reported. The IC50 values 
were 12.5 μg/mL for Caco-2, 7.99μg/mL for HeLa 
cells 43.4μg/mL for HepG2 cells and 12.4 μg/mL for 
LNCaP cells. The proteasome complex has been 
considered an important target for anti-cancer drugs. 
Inhibition of 26S proteasome complex induces 
apoptosis and helps in slowing down cancer 
progression.10 
This study confirms the anti-cancer properties 
of Murraya koenigii leaves extracts and demonstrates 
that the anti-cancer effects might be mediated through 
inhibition of 26S proteasome complex. The current 
data shows promise and further research should 
concentrate on improving effectiveness of the extract 
against cancer cells. Dose response data from this 
study will be helpful in designing future projects to 
elucidate the exact mechanisms underlying the 
observed anti-cancer, proteasome inhibiting 
properties. Understanding the mechanism of action 
will help in determining the possibilities of 
combination therapies either with molecules acting 
through a similar mechanism or with other anti-cancer 
drugs for synergistic effects. A number of alkaloids 
and flavonoids have been identified as the major 
bioactive components of Murraya koenigii.11 Therefore, 
future research should also identify the bioactives 
responsible for the anti-cancer properties of Murraya 
koenigii leaves. Although finding a cure for cancer has 
been challenging, newer therapeutic techniques offer 
hope to the future of cancer treatment.         
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